Cittá della Salute e della Scienza di Torino

Torino 10126

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-cell Lymphoma, MDS, Myelodysplastic Syndrome, RAEB, Refractory Anemia With Excess Blasts

Studies at this site

• Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) — Running, not enrolling
• Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMA — Stopped early